These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists. Lynch JJ; Rahwan RG; Lucchesi BR Eur J Pharmacol; 1985 Apr; 111(1):9-15. PubMed ID: 3874780 [TBL] [Abstract][Full Text] [Related]
29. Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue. Bénardeau A; Weissenburger J; Hondeghem L; Ertel EA J Pharmacol Exp Ther; 2000 Feb; 292(2):561-75. PubMed ID: 10640293 [TBL] [Abstract][Full Text] [Related]
30. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Elharrar V; Gaum WE; Zipes DP Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. Alexanian AR; Arutyunian NS; Galoyan AA Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of Na+/Ca2+ overload with R 56,865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs. Lu HR; Remeysen P; De Clerck F Eur J Pharmacol; 1993 Apr; 235(1):89-93. PubMed ID: 8519283 [TBL] [Abstract][Full Text] [Related]
33. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments. Kohajda Z; Farkas-Morvay N; Jost N; Nagy N; Geramipour A; Horváth A; Varga RS; Hornyik T; Corici C; Acsai K; Horváth B; Prorok J; Ördög B; Déri S; Tóth D; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Baczkó I; Leprán I; Nánási PP; Papp JG; Varró A; Virág L PLoS One; 2016; 11(11):e0166041. PubMed ID: 27832106 [TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic and hemodynamic effects of prifuroline. Benharkate M; Plassard G; Legeai J; Worcel M Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836 [TBL] [Abstract][Full Text] [Related]
35. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action. Curtis MJ; Barsby RW; Forster R J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134 [TBL] [Abstract][Full Text] [Related]
36. In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions. Hashimoto K; Nakagawa Y; Nabata H; Imai S Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):212-21. PubMed ID: 646520 [TBL] [Abstract][Full Text] [Related]
37. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity. Damiano BP; Stump GL; Yagel SK J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842 [TBL] [Abstract][Full Text] [Related]
38. Antiarrhythmic activity of cetiedil and its analogues. Haring J; Mesangeau D; Huet Y; Aurousseau M Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):467-81. PubMed ID: 6110633 [TBL] [Abstract][Full Text] [Related]
39. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). Bergey JL; Sulkowski T; Much DR; Wendt RL Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506 [TBL] [Abstract][Full Text] [Related]
40. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion. Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]